Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group. [electronic resource]
Producer: 19901204Description: 204-10 p. digitalISSN:- 0012-1797
- Adult
- Autoantibodies -- immunology
- Cyclosporins -- therapeutic use
- Diabetes Mellitus, Type 1 -- drug therapy
- Double-Blind Method
- Female
- Follow-Up Studies
- HLA-DR Antigens -- genetics
- Humans
- Immunosuppression Therapy
- Insulin Antibodies -- immunology
- Islets of Langerhans -- immunology
- Male
- Phenotype
- Predictive Value of Tests
- Prospective Studies
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.